The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this approach offers a more convenient way to deliver https://aadamrdnk554336.howeweb.com/41623368/glp-1-patches-a-novel-approach-to-blood-sugar-management